Panel Discussion: Trailblazing Next-Generation of ADCs from XDCs to Dual Payload Innovation to Develop Safer & More Efficacious ADC Drugs from Concept to Clinical Validation
9:00 am - Wednesday 10th March 2027
- Debating the optimal chemical and biological properties of next-generation payload and linker combinations
- Exploring the novelty of dual-payload ADCs and their potential to overcome resistance and improve safety profiles compared to traditional ADCs
- Assessing the potential of novel ‘XDC’ candidates to expand therapeutic applications and unlock untapped opportunities within an increasingly crowded ADC landscape
